AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2022 inter alia to consider and approve We hereby inform pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that a Meeting of the Board of Directors of the Company will be held on Wednesday February 9 2022 to consider and approve inter alia the following:1. Standalone & Consolidated Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31 2021 and2. Payment of Third Interim Dividend if any for the financial year 2021-22.Further to our letter dated December 29 2021 informing the closure of Trading Window of the Company from January 1 2022 until 48 hours from the date of declaration of the Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31 2021 we inform you that the Trading Window will remain closed up to February 11 2022 and shall be re-opened on February 12 2022.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
